Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
Analysis Finds Clinical Insights for Treating AIHA, Non-Hodgkin LymphomaFebruary 22nd 2020
Though rare, patients with both autoimmune hemolytic anemia (AHIA) and non-Hodgkin lymphoma face stark odds of long-term survival. A new study lends insights into how to best diagnose and treat those patients.
Edge Detection Might Help Determine Differences in Patients With Far-Advanced GlaucomaFebruary 20th 2020
There’s significant evidence that some patients with far-advanced glaucoma are able to perform more tasks than others. Yet, it’s difficult to distinguish these patients from each other. A new study proposes a way to find out.
Going Paleo? Study Says It's No Better Than Other Diets for Glucose, Insulin RegulationFebruary 17th 2020
There’s not much research available comparing the Paleolithic diet to other popular nutritional plans. A new study sought to scour existing data to see the Paleolithic diet’s effect on glucose and insulin regulation. The data showed no significant impact.
Immune Checkpoint Inhibitors Linked With Psoriasis Flare-ups in Rare CasesFebruary 17th 2020
Patients undergoing immunotherapy could be at risk for psoriasis flare-ups, even if the patient is asymptomatic at the initiation of cancer treatment. A newly published case report outlines a rare case where immunotherapy had to be stopped due to severe skin lesions.
Study With MS Implications Shows How Microglia Limit Macrophage Infiltration After DemyelinationFebruary 8th 2020
Scientists have long known that both microglia and blood-derived macrophages play roles in how the central nervous system responds to demyelination, which occurs in multiple sclerosis. A new study explains how the two interact.
Review Calls for Therapies to Curb Diabetic Retinopathy Prior to Vascular SymptomsFebruary 8th 2020
A new review article says neuroinflammation and oxidative stress appear to act together to weaken the diabetic retina and optic nerve; the authors say these insights could someday lead to better therapies to prevent diabetic retinopathy.
Wave of Targeted CLL Therapies Raises Questions About Autoimmune ComplicationsFebruary 5th 2020
New targeted therapies like ibrutinib, idelalisib, and venetoclax appear to be highly successful in the treatment of chronic lymphocytic leukemia (CLL), but investigators say it’s unclear how those therapies impact autoimmune complications of the cancer.